author-photo

L. Belyanskaya

7

Papers

109

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.

2019 Therapeutic advances in hematology
Show All
- Source
- Cite
- Save
Citations (8)
Estimation of Nuwiq ® (simoctocog alfa) activity using one‐stage and chromogenic assays—Results from an international comparative field study

2019 Haemophilia
Show All
- Source
- Cite
- Save
Citations (6)
Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate®: Final report from a prospective study

2018 Haemophilia
Show All
- Source
- Cite
- Save
Citations (5)
Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study

2018 Haemophilia
Show All
- Source
- Cite
- Save
Citations (19)